Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the...
from NDTV News - World-news https://ift.tt/2YkZlPf